Literature DB >> 22311818

Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.

Jin Wang1, Jian-Chun Yu, Wei-Ming Kang, Zhi-Qiang Ma.   

Abstract

BACKGROUND AND OBJECTIVES: Despite a relatively better prognosis, patients with node-negative gastric cancer still suffer from metastasis and recurrence. To investigae the prognostic factors and appropriate therapies for these pN0 tumors, we analyzed the predictors and evaluated the impact of chemotherapy and extensive lymphadenectomy on survival.
METHODS: Clinicopathologic features of 153 patients with pN0 gastric cancer were studied retrospectively. The prognostic factors were analyzed stratifying by pT1 and pT2-3 stage. The 5-year survival rate (5-YSR) of patients in different groups of chemotherapy and lymph nodes retrieved were compared.
RESULTS: Multivariate analysis indicated pT, number of nodes retrieved, and chemotherapy as the independent predictors of advanced gastric cancer; anemia was the only independent predictor of early gastric cancer. Survival of patients with pT3 got improved significantly by intraoperative chemotherapy and retrieval of more than 25 nodes, but neither of them benefited patients with pT1-2. Moreover, in pT3 status, 5-YSR of patients with intraoperative chemotherapy was still poorer than those with postoperative chemotherapy and combined chemotherapy.
CONCLUSIONS: In pN0 gastric cancers, prognostic factors differed significantly between early stage and advanced stage. For patients with pT3, besides curative gastrectomy and postoperative chemotherapy, it might be beneficial to perform intraoperative chemotherapy and extensive lymphadenectomy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22311818     DOI: 10.1002/jso.22089

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Effects of extended lymphadenectomy and postoperative chemotherapy on node-negative gastric cancer.

Authors:  Qiang Xue; Xiao-Na Wang; Jing-Yu Deng; Ru-Peng Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors.

Authors:  Yanming Zhou; Feng Yu; Lupeng Wu; Feng Ye; Leilei Zhang; Yumin Li
Journal:  Med Sci Monit       Date:  2015-07-02

3.  Seom guidelines for the treatment of gastric cancer 2015.

Authors:  M Martin-Richard; A Custodio; C García-Girón; C Grávalos; C Gomez; P Jimenez-Fonseca; J L Manzano; C Pericay; F Rivera; A Carrato
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

Review 4.  Molecular classification and prediction in gastric cancer.

Authors:  Xiandong Lin; Yongzhong Zhao; Won-Min Song; Bin Zhang
Journal:  Comput Struct Biotechnol J       Date:  2015-08-13       Impact factor: 7.271

5.  Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.

Authors:  Jiuda Zhao; Feng Du; Yu Zhang; Jie Kan; Li Dong; Guoshuang Shen; Fangchao Zheng; Hui Chen; Junhui Zhao; Faxiang Ji; Yang Luo; Fei Ma; Ziyi Wang; Binghe Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

6.  Early and late recurrences in lymph node-negative gastric cancer: a retrospective cohort study.

Authors:  Jian-Wei Sun; Dao-Li Liu; Jia-Xian Chen; Li-Zhen Lin; Lv-Ping Zhuang; Xian-Hai Hou
Journal:  Ann Saudi Med       Date:  2021-12-02       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.